Glymidine sodium is an oral active antidiabetic. Glymidine sodium is the inhibitor of hepatic lipolysis. Glymidine sodium inhibits the glucose formation and supresses the elevated pyruvate oxidation which results from the inhibition of endogenous lipid mobilization[1].
Molecular Weight:
331.32
Purity:
98.48
CAS Number:
[3459-20-9]
Formula:
C13H14N3NaO4S
Target:
Insulin Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted